Novel heterocyclic antiestrogens
US-2018354936-A1 · Dec 13, 2018 · US
Thiochromene derivatives as HIF hydroxylase inhibitors
US8927591B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8927591-B2 |
| Application number | US-200913128620-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 11, 2009 |
| Priority date | Nov 14, 2008 |
| Publication date | Jan 6, 2015 |
| Grant date | Jan 6, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to novel compounds, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of Formula I: wherein: q is 1, 2, 3, or 4; y is 0-2; R 1 is selected from the group consisting of —OR 18 , hydroxy, acyloxy, alkoxy, substituted alkoxy, cycloalkoxy, substituted cycloalkoxy, aryloxy, substituted aryloxy, heteroaryloxy, substituted heteroaryloxy, heterocyclyloxy, substituted heterocyclyloxy, thio,…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8927591B2 cover?
- The present invention relates to novel compounds, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
- Who is the assignee on this patent?
- Ho Wen-Bin, Wright Lee R, Turtle Eric D, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07D335/06. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).